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Tea is the most common beverage after water. It is extracted from the leaves of Camellia sinensis 
(family: Theaceae). It is consumed in different forms, namely, oolong, green, black and Ilex tea 
depending on post-harvest treatment and chemical components. Being rich in natural antioxidants, tea 
is reported to be used in the management of colon, esophageal, and lung cancers, as well as urinary 























*Corresponding Author:  +91 01342 2252200 E-Mail:  v_k05s@rediffmail.com   
Sharma et al                     
Trop J Pharm Res, September 2007; 6 (3) 786
INTRODUCTION 
Tea is one of the most consumed beverages of 
the world. Presently, it is cultivated in at least 30 
countries around the world. Tea beverage is an 
infusion of the dried leaves of Camellia sinesis, a 
member of Theaceae family. It is an evergreen 
shrub or tree that can grow to a height of 30 feet, 
but is usually clipped to a height of 2.5 feet in 
cultivation. The tree or shrub is heavily branched 
with dark-green, hairy, oblong, ovate leaves 
cultivated and preferentially picked as young 
shoots. Older leaves are considered to be 
inferior in quality. Freshly harvested tea leaf is 
processed differently in different parts of the 
world to give oolong tea (2%), green tea (20%) 
or black tea (78%)1. Green tea is prepared from 
the fresh tea leaf and widely consumed in Japan 
and China. Western cultures favour black tea 
which is prepared through the oxidation, curing 
process of maceration and exposure to 
atmospheric oxygen2,3. The consumption of 
oolong tea is mostly confined to China and 
Taiwan, and roasted tea is consumed mostly in 
Japan. Green and roasted teas are steamed, 
respectively, to avoid enzymatic oxidation; 
oolong tea is semi-fermented to permit a 
moderate level of enzymatic oxidation during 
processing2,4,5. Also, Ilex paraguayensis is a 
species of tea from South America. This plant is 
processed to obtain a final commercial product 
named yerba mate. The mate is a famous 
popular tea consumed in Argentina, Brazil, 
Uruguay, and Paraguay. Even though the 
therapeutic properties of yerba mate have been 
extensively explored, there are few studies of 
chemical composition of mate2,6,7.  
 
‘Healthy Foods’ containing active scavengers of 
free radicals are very popular nowadays. 
Advertisements in newspapers and magazines 
regarding a “Wonder Cure” that prevent damage 
to the body are becoming ubiquitous. It is widely 
accepted that phenolic compounds contained in 
certain foods have potential health benefits. Tea 
is linked to beneficial effects on human health 
with the polyphenols as the responsible 
constituents1,8,9.  
                          Tea leaves as well as the 
resulting beverage tea are known to possess 
high amounts of polyphenols, especially 
flavanols, the so called catechins5,10. Many in 
vitro and in vivo effects of tea polyphenols have 
been reported11,12,13 including antioxidant, 
anticarcinogenic and hypolipidemic properties.  
 
Chemical composition of tea  
In making green tea, the tea leaves are heated 
to inactivate the enzymes and dried. Thus the 
constituents of the tea leaves are preserved in 
the dried tea leaves. When the tea leaves are 
brewed, for example 2.5 g in 250 ml of hot water 
for 3 minutes, about 30% of the solid materials 
are extracted into water. The spray-dried powder 
of the water extract, known as green tea solids, 
has been used for animal experiments. All teas 
are rich in polyphenolic compounds which are 
also present in red wine, fruit and 
vegetables14.Fresh tea leaf is rich in water 
soluble polyphenols, particularly flavanols, 
flavanol gallate and flavanol glycosides2,15,16.The 
major tea catechins: α-epigallocatechin-3-gallate 
(EGCG), α-epigallocatechin (EGC), α-
epicatechin-3-gallate (ECG), α-epicatechin (EC), 
α-epicatechin-3-gallate (ECG), α-epicatechin 
(EC), α-gallocatechin and β-catechin; constitutes 
30% to 42% of the green tea solids by 
weight17.Caffeine accounts for 3% to 6%. The 
composition varies with the cultivation conditions 
and subsequent processing of the tea. Black tea 
(‘Black’ used in this context relates solely to the 
method of leaf processing and not to the optional 
addition of milk to the beverage before 
consumption) is produced from fresh green leaf 
by ‘enzymatic browning processes (driven by 
polyphenol oxidase) and coupled chemical 
oxidation of the flavanols and flavanol gallates 
and, to   lesser extent, the flavanol (especially 
myricetin) glycosides and the non-flavanoid 
theagallin. These transformations produce a 
unique range of pigments including the brownish 
thearubigins and the red-orange theaflavins, 
theaflavic acids and theaflavins, as reviewed by 
Harbowy and Balentine18. The thearubigins are 
the major polyphenols of black tea leaf and 
beverage. Their content has been variously 
estimated as 3-6%. In this process, commonly 
referred to as fermentation, the caffeine content 
in the tea leaves is not significantly changed. 
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Theaflavins contribute to the taste, the bright red 
orange colour of black tea, and account for 2% 
to 6% of the dry weight of black tea extracts. The 
major theaflavins are theaflavin-3-digallate, 
theaflavin-30-gallate and theaflavin-3, 30-
digalalte.Black tea contains greater proportion of 
the complex catechins such as epigallocatechin 
gallate and other phenols such as theaflavins 
and the rubigins generated by the oxidation 
processes used in tea production19. Dall Orto et 
al9 reported the presence of flavonoids and 
phenolic compounds (p-coumeric and ferulic 
acid) in about 10% of dry weight in yerba mate7. 
 
Tea with antioxidant property  
In human body, different protection mechanisms 
are present to combat free radicals. Also, there 
is equilibrium between pro-oxidative and anti-
oxidant process, and when this equilibrium is 
disturbed in favour of free radicals, oxidation 
stress results20.The oxidation of lipoproteins 
plays an important role in the development of 
atherosclerosis by means of oxidation process, 
low density lipoproteins (LDL) of vascular walls. 
LDLs are very rich in cholesterol causing change 
in structure of vascular walls. These structural 
modifications encourage macrophages to pick 
up the oxidized LDL, promoting a change into 
foam cells. A collection of these cells in the 
vascular walls leads to the first noticeable 
change of cellular tissue, called fatty strreaks. 
These changes can result in the total closure of 
the artery, which could cause angina or vascular 
occlusion. It is well established that other 
pathological states such as cancer, rheumatoid 
arthritis, ischaemic reoxygenation injury of the 
liver and other organs, are set of by oxidation 
processes20,21.        
 
The powerful antioxidant properties of the tea 
are generally attributed to its flavonoid 
components; theaflavins, bisflavanols and 
theaflavic acids22.These compounds are all 
potent antioxidant in vitro and, when consumed, 
may act as the free radical scavengers which 
remove endogenously generated superoxide, 
peroxyl and hydroxyl radicals. The antioxidant 
property of tea is also associated with several 
other mechanisms e.g. depolarization of 
electrons, formation of intramolecular hydrogen 
bonds23, rearrangement of the molecular 
structure24,25.These compounds may also 
prevent oxidative reactions by chelating free 
copper and iron, which may catalyze the 
formation of reactive oxygen species in vitro26,27. 
 
The antioxidant flavanoids appear to be readily 
taken up by the human gastrointestinal tract. 
Van het Hoff  et al28 have demonstrated that tea 
catechins, from both green and black teas, 
appear in human plasma and in circulating 
lipoprotein fractions28. Five cups of tea 
consumed at 2-hours intervals was sufficient to 
elevate plasma catechin concentrations by up to 
12-fold in a UK based study. The consumption of 
black tea with milk did not impair the 
bioavailability of the tea catechins29. Maxwell 
and Thrope30 reported that tea consumption had 
no effect on total plasma antioxidant status30. 
Conversely, Serafini et al31 reported that green 
and black teas significantly elevated plasma 
antioxidant potential, as measured using a 
fluorescence assay. Beverage tea, rich in 
antioxidant polyphenols, affects host 
biochemistry and carcinogenesis at important 
target organs such as colon or mammary glands 
in rats32. This depletion of antioxidant power is 
observed with soya milk as well as cow’s milk 
and in less marked with skimmed and semi-
skimmed milks. It suggests that the depletion of 
antioxidant effect is due to associations between 
the tea flavanoids and milk fat rather than 
proteins3,33. 
 
Tea with anticancer property  
Many epidemiological, case-control, and cohort 
studies have been conducted to investigate the 
effects of tea consumption on human cancer 
incidence, and this topic has been reviewed by 
several authors34,35,36,37. In a Japanese cohort 
study, a negative association was found 
between green tea consumption and total cancer 
incidence, especially among females drinking 
more than 10 cups per day38. The effect of tea 
on stomach cancer has been the most 
extensively studied.. Of 15 studies, five case-
control studies showed a protective effect of tea 
on the risk of stomach cancer39,40,41,42. Several 
studies have been done on tea drinking and 
colorectal cancer, with inconclusive or no 
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evidence of an association. A recent study on 
middle-aged Finnish men indicated a positive 
association between increased green tea 
consumption and colon cancer risk43. However, 
the results with green tea showed a protective 
effect of tea36,37. A large study of pancreatic, 
colon, and rectal cancers indicated decreased 
incidents of these cancers with consumption of 
tea44. The results from the epidemiological 
studies regarding tea intake and lung cancer are 
unclear because smoking factor was not taken 
into account in the study design. There is also 
some evidence that green tea polyphenols have 
a chemopreventive effect against cancers in 
smokers45. The frequency of sister-chromatid 
exchange in lung cells was lower in smokers 
who consumed green tea. In a seven-year 
follow-up study of patients with breast cancer, it 
was found that increased consumption of green 
tea was associated with decreased numbers of 
axillary lymph node metastases especially 
among premenopausal patients with stage I and 
II breast cancers46. Early studies have linked tea 
drinking to both increased and decreased risks 
of esophageal cancers, but recent studies have 
shown that the positive association between tea 
and esophageal cancer was because of the high 
temperature at which the tea is consumed. 
Findings from the largest study of esophageal 
cancer conducted in China suggested that, 
barring the effect of temperature, drinking green 
tea decreases the risk of esophageal cancer47. 
The anti-carcinogenic activities of tea 
polyphenols are generally believed to be related 
to their antioxidative properties. Tea may affect 
the metabolism of carcinogens by induction or 
inhibition of various cytochrome P450s, but the 
practical importance of this mechanism is not 
known. Among the phase II enzymes, tea 
increases glucuronyl transferase activity, which 
may facilitate the detoxification pathway of 
certain carcinogens. Inhibition of tumor 
promotion-related enzymes, such as 
lipoxygenase and cyclooxygenase48,49, ornithine 
decarboxylase50,51,52, protein kinase C52,53,54, and 
5α steroid reductase isoenzymes35 has been 
shown. The antiproliferative effect of tea 
polyphenols has been demonstrated at both the 
initiation stage55 and the progression stage55 of 
lung tumorigenesis. In cell lines, EGCG and 
other tea catechins have been shown to inhibit 
cell growth and transformation. Some of these 
activities are believed to be attributable to the 
inhibition of MAP-kinases and AP-1 
activities56,57. Fujiki et al58 demonstrated that 
EGCG and other tea polyphenols inhibit growth 
of human lung cancer cells with a G2/M phase 
arrest of the cell cycle. The involvement of the 
tumor necrosis factor α pathway in the inhibition 
process has been suggested. EGCG and other 
tea polyphenols have been shown to inhibit the 
phosphorylation of Rb by Cdk2/459 and the 
binding of epidermal growth factor and TPA to 
their respective receptors and thus inhibit tumor 
promotion59,60. Green tea polyphenols also 
enhance apoptosis, and this has been shown in 
many cancer cell lines such as PC-9, H661, 
KATO III, DU145, A431, LY-R, HaCaT, W138, 
and Molt-4361. This study suggests that a 
prooxidative mechanism may be involved62. 
EGCG has also been shown to inhibit 
angiogenesis by inhibiting the growth of 
endothelial cells whereas green tea reduced 
significantly vascular endothelial growth factor-
induced corneal neovascularization63. 
 
Green tea and ethanol intoxication  
The defense against long-term ethanol exposure 
is provided by both endogenously synthesised 
and exogenous antioxidants. The latter are 
derived from beverages and diet. The 
therapeutic effect of green tea is associated with 
its catechins. Catechins are polyphenols with 
two hydroxyl groups in the B ring of the catechin 
molecule. These compounds possess the ability 
of preventing the formation of oxygen radicals, 
by inhibiting the activity of the enzymes involved 
in their generation. The liver is the richest source 
of xanthine oxidase, especially during ethanol 
metabolism64. Green tea extract inhibits the 
activity of xanthine oxidase in vitro, thus 
inhibiting superoxide anion generation65. Long-
term ethanol exposure leads to an increase in 
the concentration of free ferrous ions which 
catalyze the Haber-Weiss reaction and hydroxyl 
radical generation and in result to an increase in 
lipid peroxidation. Catechins may diminish pro-
oxidative action of transition metal ions by 
chelate formation. It is suggested that catechins 
can serve as scavengers of aqueous peroxyl 
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radicals near the membrane surface while α-
tocopherol within the membrane66. 
 
Anticaries effect of tea  
With respect to the effect of tea extracts on 
dental caries, Oolong tea extract (OTE) has 
been reported to contain substances, notably 
polyphenols, that have antibacterial properties 
against oral pathogens, such as Streptococcus 
mutans, the bacteria closely associated with 
dental caries67,68. Some studies suggested that a 
diet supplemented with green tea may beneficial 
in dental caries management67,69,70. Lingstro¨m 
et al71 found that frequent mouth rinsing with 
black tea infusion may contribute to oral health 
by inhibition of plaque, its acidity and its 
cariogenic microflora. Green tea and coffee 
contain varying amounts of fluoride72,73. 
Cariostatic properties of fluoride in water supply, 
dentifrices and topical gels have been 
documented74,75. However, most of the reports 
suggest that the anti-caries effect observed with 
green tea is due primarily to the antibacterial 
properties of the organic components 
(polyphenols, tannins) rather than the cariostatic 
effect of fluoride69,76. 
  
Tea contains substances, such as polyphenols, 
that were shown to have antibacterial properties 
against cariogenic bacteria, especially S. 
mutans77,78. The polyphenols in green tea were 
reported to have an inhibitory effect on growth 
and cellular adherence of Porphyromonas 
gingivalis, an oral bacterium that causes 
periodontal disease79. 
 
Other effects  
A cross-sectional study of 1276 older women 65 
to 76 years) in the U.K. found that tea drinkers 
had significantly higher bone mineral density 
BMD) at the lumbar spine and hip than 
nondrinkers80. The mechanisms for a beneficial 
effect of tea consumption on bone mineral 
density are not clear. Although tea is a relatively 
good source of fluoride, an element known to 
increase bone density in pharmacologic doses, 
there is little evidence that the amount of fluoride 
supplied by tea would significantly affect 
BMD81.The oxidative stress-responsive 
transcription factor, NF- has been found recently 
to play a role in bone resorption, and increased 
levels of urinary 8-iso-PGF2α, a biomarker for 
oxidative stress, were significantly associated 
with decreased lumbar spine and total body 
BMD in a cross-sectional study of 101 men and 
women82. Tea polyphenols could potentially 
inhibit bone resorption by decreasing B 
activation, decreasing oxidative stress or 
inhibiting NF-. 
 
High fluid intake, including tea intake, is 
generally considered the most effective and 
economical means of preventing kidney 
stones83. However, tea consumption has been 
found to increase urinary oxalate levels in 
healthy individuals84, and some experts continue 
to advise those prone to calcium oxalate stone 
formation to limit tea consumption85. 
 
CONCLUSION 
Most of the effects of tea are associated with 
flavonoids and their antioxidant potential. These 
manifest counter acting power of body towards 
naturally generated or externally invaded 
oxidizing species. The polyphenols present in 
tea can also decrease the risk factor of specific 
type of cancers by inducing phase I and phase II 
metabolic enzymes that increase the formation 
and excretion of detoxified metabolites of 
carcinogens. The research interest based on tea 
components may provide an approach to 
decrease the incidence of and mortality from 
various diseases. Overall tea is an affordable 
beverage of natural origin compared to modern 
beverages such as soft drinks. 
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